Sens. Introduce Bill To Ban Pay-For-Delay Deals

Law360, New York (February 5, 2013, 4:58 PM EST) -- A bipartisan pair of senators said Tuesday they have introduced legislation meant to block so-called pay-for-delay agreements, the potentially anti-competitive pharmaceutical patent settlements that keep generic drugs off the market.

Sens. Amy Klobuchar, D-Minn., and Chuck Grassley, R-Iowa, proposed a bill that would crack down on pay-for-delay deals, in which a brand-name pharmaceutical company pays to keep a generic-drug manufacturer from bringing its drug to market for a certain period of time, according to a statement issued Tuesday by Klobuchar's office. Sens. Al Franken, D-Minn., Dick...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.